Literature DB >> 16363854

Synthesis, structures, and magnetic properties of the copper(II), cobalt(II), and manganese(II) complexes with 9-acridinecarboxylate and 4-quinolinecarboxylate ligands.

Xian-He Bu1, Ming-Liang Tong, Ya-Bo Xie, Jian-Rong Li, Ho-Chol Chang, Susumu Kitagawa, Joan Ribas.   

Abstract

To explore the relationships between the structures of ligands and their complexes, we have synthesized and characterized a series of metal complexes with two structurally related ligands, 9-acridinecarboxylic acid (HL(1)) and 4-quinolinecarboxylate acid (HL(2)), [Cu(2)(mu(2)-OMe)(2)(L(1))(2)(H(2)O)(0.69)](n) 1, [Cu(2)(L(1))(4)(CH(3)OH)(2)] 2, [Cu(3)(L(1))(6)(CH(3)OH)(6)].3H(2)O 3, [Mn(3)(L(1))(6)(CH(3)OH)(6)].3H(2)O 4, [Co(3)(L(1))(6)(CH(3)OH)(6)].3H(2)O 5, [Cu(L(2))(2)](n) 6, [Mn(L(2))(2)(H(2)O)](n) 7, and [Co(L(2))(2)(H(2)O)](n) 8. 1 is a three-dimensional (3D) polymer with an interpenetrating NbO type network showing one-dimensional (1D) channels, whereas 2 and 3 take bi- and trinuclear structures, respectively, because of the differences in basicity of the reaction systems in preparing the three complexes. 4 and 5 have trinuclear structures similar to that of 3. In 1-5, ligand L(1) performs different coordination modes with N,O-bridging in 1 and O,O'-bridging in 2-5, and the metal ions also show different coordination geometries: square planar in 1, square pyramidal in 2, and octahedral in 3-5. 6 has a two-dimensional structure containing (4,4) grids in which L(2) adopts the N,O-bridging mode and the Cu(II) center takes square planar geometry. 7 and 8 are isostructural complexes showing 1D chain structures, with L(2) adopting the O,O-bridging mode. In addition, the intermolecular O-H...N hydrogen bonds and pi-pi stacking interactions further extend the complexes (except 1 and 6), forming 3D structures. The magnetic properties of 2-7 have been investigated and discussed in detail.

Entities:  

Year:  2005        PMID: 16363854     DOI: 10.1021/ic050886d

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  8 in total

1.  catena-Poly[zinc(II)-μ-aqua-κO:O-bis-(μ-quinoline-4-carboxyl-ato-κO:O')].

Authors:  Jin-Xi Chen; Wei-Wei Meng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-04

2.  catena-Poly[silver(I)-μ-acridine-9-carboxyl-ato-κN:O,O'].

Authors:  Ya-Qing Yang; Xiao-Ye Chen; Shu-Min Huo; Yan-Ru Ma; Rong-Hua Zeng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-30

3.  Tetra-aqua-bis(2-oxo-1,2-dihydro-quinoline-4-carboxyl-ato-κO)nickel(II).

Authors:  Gang Yuan; Jun-Sheng Qin; Zhong-Min Su; Kui-Zhan Shao; Yao-Mei Fu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-01-23

4.  Tetra-aqua-hexa-kis(μ(2)-quinoline-4-carboxyl-ato)diyttrium(III) dihydrate.

Authors:  Chao-Yan Zhang; Qian Gao; Yue Cui; Ya-Bo Xie
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-29

5.  Synthesis, crystallographic, spectroscopic studies and biological activity of new cobalt(II) complexes with bioactive mixed sulindac and nitrogen-donor ligands.

Authors:  Asia M Shalash; Hijazi I Abu Ali
Journal:  Chem Cent J       Date:  2017-05-10       Impact factor: 4.215

6.  Crystal structure and DFT study of benzyl 1-benzyl-2-oxo-1,2-di-hydro-quinoline-4-carboxyl-ate.

Authors:  Younos Bouzian; Md Serajul Haque Faizi; Joel T Mague; Bouchaib El Otmani; Necmi Dege; Khalid Karrouchi; El Mokhtar Essassi
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-06-11

7.  Tetra-kis(μ-2-phenyl-quinoline-4-carboxyl-ato-κ(2)O:O')bis-[(methanol-κO)copper(II)].

Authors:  Junfang Guo; Guoping Yan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-26

8.  A 3-D metal-organic framework constructed with manganese(ΙΙ), 4,4'-oxybis(benzoic acid) and 2,2'-biphenyl: synthesis, crystal structure and photoelectric property characterization.

Authors:  Kai-Sheng Diao; Long Li; Yu-Qiu Ding; Fu-Hou Lei
Journal:  Molecules       Date:  2012-09-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.